Slideshows Images Quizzes

Tobradex ST

Last reviewed on RxList: 11/10/2016
Tobradex ST Side Effects Center

Last reviewed on RxList 3/21/2016

Tobradex ST (tobramycin/dexamethasone) Ophthalmic Suspension 0.3%/0.05% a combination antibiotic and steroid used to treat bacterial infections of the eyes. Common side effects of Tobradex ST include:

  • eye redness
  • eye discomfort
  • burning
  • stinging
  • irritation
  • itching
  • blurred vision
  • eyelid itching or swelling, or
  • sensitivity to light.

One drop of Tobradex ST ophthalmic should be instilled into the eye(s) every four to six hours. During the initial 24 to 48 hours the dosage may be increased to one drop every two (2) hours. Do not use other eye drops or medications during treatment with Tobradex ST ophthalmic unless directed by your doctor. Tobradex ST may interact with oral steroid medications. Tell your doctor all prescription or over-the-counter medicines or supplements you use. Tobradex should be used only when prescribed during pregnancy. It is unknown if Tobradex ST passes into breast milk. Consult your doctor before breastfeeding.

Our Tobradex ST (tobramycin/dexamethasone) Ophthalmic Suspension 0.3%/0.05% Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Tobradex ST Consumer Information

Serious side effects are not expected to occur with the use of this medication.

Some burning, stinging, irritation, itching, redness, blurred vision, eyelid itching, eyelid swelling, or sensitivity to light may occur.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Read the entire detailed patient monograph for Tobradex ST (Tobramycin / Dexamethasone Ophthalmic Suspension 0.3%/0.05%)

Tobradex ST Professional Information


Adverse reactions have occurred with steroid/anti-infective combination drugs which can be attributed to the steroid component, the anti-infective component, or the combination. Exact incidence figures are not available.

The most frequent adverse reactions to topical ocular tobramycin (TOBREX® ) are hypersensitivity and localized ocular toxicity, including eye pain, eyelids pruritus, eyelid edema, and conjunctival hyperemia. These reactions occur in less than 4% of patients. Similar reactions may occur with the topical use of other aminoglycoside antibiotics.

The reactions due to the steroid component are: increased intraocular pressure (IOP) with possible development of glaucoma, and infrequent optic nerve disorder; subcapsular cataract; and impaired healing.

Secondary Infection.

The development of secondary infection has occurred after use of combinations containing steroids and antimicrobials. Fungal infections of the cornea are particularly prone to develop coincidentally with long-term applications of steroids. The possibility of fungal invasion must be considered in any persistent corneal ulceration where steroid treatment has been used. Secondary bacterial ocular infection following suppression of host responses also occurs.

Non-ocular adverse events occurring at an incidence of 0.5% to 1% included headache and increased blood pressure.

Read the entire FDA prescribing information for Tobradex ST (Tobramycin / Dexamethasone Ophthalmic Suspension 0.3%/0.05%)

Related Resources for Tobradex ST

Read the Tobradex ST User Reviews »

© Tobradex ST Patient Information is supplied by Cerner Multum, Inc. and Tobradex ST Consumer information is supplied by First Databank, Inc., used under license and subject to their respective copyrights.

Health Solutions From Our Sponsors